Inovio Pharmaceuticals Inc. Stock Sheds 21.3%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. cratered 21.3% to $0.80 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,702.86 and the Dow Jones Industrial Average rising 0.7% to 52,856.09.

The stock's fall snapped a two-day winning streak.

Inovio Pharmaceuticals Inc. closed 70.8% short of its 52-week high of $2.72, which the company reached on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.6% to $257.78, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.86% to $29.85.

Trading volume totaled 11.2 million, compared to the 50-day average of 3.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 21, 2026 16:33 ET (20:33 GMT)